ProfileGDS4284 / 224955_at
TitleChronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood
OrganismHomo sapiens


control 0.2 mg/kg 1 mg/kg 2 mg/kg 4 mg/kg 6 mg/kg pre-treatment 24 hrs 4 wks 24 hrs 4 wks 24 hrs 4 wks 4 hrs 24 hrs 4 wks 4 hrs 24 hrs 4 wks 401 402 403 404 411 422 424 425 427 428 441 443 444 448 449 450 451 452 401 402 411 402 411 422 403 424 427 403 424 427 428 449 450 425 428 443 444 449 450 425 428 443 449 450 404 448 451 452 404 441 448 451 452 451 452 GSM687644 GSM687648 GSM687653 GSM687658 GSM687663 GSM687668 GSM687673 GSM687678 GSM687683 GSM687688 GSM687695 GSM687699 GSM687704 GSM687707 GSM687712 GSM687719 GSM687724 GSM687728 GSM687646 GSM687649 GSM687665 GSM687651 GSM687667 GSM687670 GSM687671 GSM687654 GSM687675 GSM687685 GSM687656 GSM687677 GSM687687 GSM687692 GSM687716 GSM687722 GSM687680 GSM687690 GSM687700 GSM687705 GSM687714 GSM687721 GSM687682 GSM687694 GSM687702 GSM687718 GSM687723 GSM687661 GSM687710 GSM687726 GSM687730 GSM687660 GSM687697 GSM687709 GSM687725 GSM687729 GSM687727 GSM687731 36% 3% 31% 17% 29% 26% 38% 27% 30% 43% 57% 33% 36% 35% 30% 58% 34% 30% 33% 29% 3% 43% 35% 38% 19% 25% 20% 27% 24% 26% 45% 34% 31% 56% 27% 18% 1% 8% 33% 59% 5% 24% 27% 38% 68% 44% 27% 36% 45% 46% 60% 40% 8% 40% 35% 29% sort by dose sort by time sort by individual Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM687644Patient 401 control100.01736
GSM687648Patient 402 control6.761163
GSM687653Patient 403 control76.554431
GSM687658Patient 404 control31.819617
GSM687663Patient 411 control84.140529
GSM687668Patient 422 control62.42426
GSM687673Patient 424 control125.56438
GSM687678Patient 425 control71.904927
GSM687683Patient 427 control86.961230
GSM687688Patient 428 control153.70243
GSM687695Patient 441 control403.72457
GSM687699Patient 443 control113.81333
GSM687704Patient 444 control107.47636
GSM687707Patient 448 control128.835
GSM687712Patient 449 control81.281430
GSM687719Patient 450 control381.57158
GSM687724Patient 451 control116.79334
GSM687728Patient 452 control89.164730
GSM687646Patient 401 treated 24h90.564433
GSM687649Patient 402 treated 24h66.715529
GSM687665Patient 411 treated 24h8.722593
GSM687651Patient 402 treated 4 weeks160.58743
GSM687667Patient 411 treated 4 weeks105.15935
GSM687670Patient 422 treated 24h126.86638
GSM687671Patient 422 treated 4 weeks36.292919
GSM687654Patient 403 treated 24h50.208325
GSM687675Patient 424 treated 24h44.865620
GSM687685Patient 427 treated 24h65.332127
GSM687656Patient 403 treated 4 weeks47.141824
GSM687677Patient 424 treated 4 weeks59.871526
GSM687687Patient 427 treated 4 weeks154.53745
GSM687692Patient 428 treated 4h102.38734
GSM687716Patient 449 treated 4h84.051231
GSM687722Patient 450 treated 4h335.41756
GSM687680Patient 425 treated 24h65.112627
GSM687690Patient 428 treated 24h34.087918
GSM687700Patient 443 treated 24h7.954191
GSM687705Patient 444 treated 24h13.00158
GSM687714Patient 449 treated 24h83.593333
GSM687721Patient 450 treated 24h422.12759
GSM687682Patient 425 treated 4 weeks9.353725
GSM687694Patient 428 treated 4 weeks47.357524
GSM687702Patient 443 treated 4 weeks70.547827
GSM687718Patient 449 treated 4 weeks122.51438
GSM687723Patient 450 treated 4 weeks667.57268
GSM687661Patient 404 treated 4h169.85144
GSM687710Patient 448 treated 4h64.365827
GSM687726Patient 451 treated 4h129.08736
GSM687730Patient 452 treated 4h353.20545
GSM687660Patient 404 treated 24h219.68646
GSM687697Patient 441 treated 24h463.78860
GSM687709Patient 448 treated 24h144.50640
GSM687725Patient 451 treated 24h17.79998
GSM687729Patient 452 treated 24h180.94740
GSM687727Patient 451 treated 4 weeks128.76935
GSM687731Patient 452 treated 4 weeks88.316529